Assyro AI

FDA Orange Book · active-ingredient family

Glyburide; metformin hydrochloride

Glyburide; metformin hydrochloride is approved as 1 brand and 7 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:GLUCOVANCE · NDA 021178

1

Brand (NDA)

7

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · tablet

ProductApplicantApplicationTEApproved
GLUCOVANCERLD×3BRISTOL MYERS SQUIBBNDA 021178Jul 31, 2000

Generic (ANDA) products (7)

ProductApplicantApplicationTEApproved
GLYBURIDE AND METFORMIN HYDROCHLORIDE×3ZYDUS PHARMSANDA 206748ABFeb 29, 2016
GLYBURIDE AND METFORMIN HYDROCHLORIDE×3HERITAGEANDA 079009ABJun 03, 2009
GLYBURIDE AND METFORMIN HYDROCHLORIDE×3AUROBINDO PHARMAANDA 077870ABNov 14, 2007
GLYBURIDE AND METFORMIN HYDROCHLORIDE×3ACTAVIS ELIZABETHANDA 076716ABJun 28, 2005
GLYBURIDE AND METFORMIN HYDROCHLORIDE×3TEVAANDA 076821Jan 27, 2005
GLYBURIDE AND METFORMIN HYDROCHLORIDE×3IMPAX LABS INCANDA 076731Nov 19, 2004
GLYBURIDE AND METFORMIN HYDROCHLORIDE×3IMPAXANDA 076345ABFeb 18, 2004

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Glyburide; metformin hydrochloride — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.